3D細胞培養市場：製品別（ハイドロゲル、ECM、ハンギングドロップ、バイオリアクター、マイクロ流体、磁気浮上）、用途別（癌、幹細胞、組織工学）、エンドユーザー別（製薬、バイオテクノロジー、研究）、地域別 - 2028年までの世界予測

3D Cell Culture Market by Product (Hydrogels, ECM, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Tissue Engineering), End User (Pharma, Biotech, Research), Region - Global Forecast to 2028

世界の3D細胞培養市場規模は、2023年の13億米ドルから2028年には25億米ドルに達し、予測期間中のCAGRは14.6％になると予測されている。3D細胞培養の採用増加や3D細胞培養研究への資金増加などの要因が、市場成長... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2023年7月13日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	237	244	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

世界の3D細胞培養市場規模は、2023年の13億米ドルから2028年には25億米ドルに達し、予測期間中のCAGRは14.6％になると予測されている。3D細胞培養の採用増加や3D細胞培養研究への資金増加などの要因が、市場成長を牽引している。
"足場ベースの3D細胞培養製品セグメントは、予測期間中、薬剤クラス別に3D細胞培養市場で最も高い成長率を占めた"
製品別に見ると、3D細胞培養市場は足場ベースの3D細胞培養、足場なしの3D細胞培養、マイクロ流体ベースの3D細胞培養、磁気＆バイオプリント3D細胞培養に区分される。足場ベースの3D細胞培養セグメントは2022年に最大のシェアを占めた。様々な製薬業界におけるハイドロゲル需要の高まりは、足場ベースの3D細胞培養市場の成長に好影響を与えそうだ。
"がん・幹細胞研究分野が2022年に用途別で最大シェアを占める"
用途に基づき、市場は癌・幹細胞研究、創薬・毒性試験、組織工学・再生医療に区分される。がん・幹細胞分野の研究は、2022年の市場で最大の市場シェアを占めている。癌の有病率の増加、政府および民間部門による癌研究のための重要な資金援助イニシアティブは、この応用分野の成長を促進する主な要因である。
"アジア太平洋地域はより速いペースで成長する可能性が高い"
3D細胞培養市場は、欧州、アジア太平洋、北米、ラテンアメリカ、中東・アフリカに区分される。APAC市場は、有利な規制ガイドラインの存在、細胞培養ベースのワクチン製造に対する政府の支援、低い製造コスト、世界の市場プレイヤーのアジア新興国への注目の高まりにより、予測期間中に最も急成長する地域セグメントとなる見込みである。
本レポートのために実施した一次インタビューは以下のように分類できる：

- 回答者別供給側70％、需要側30
- 回答者の役職別（サプライサイド）マネージャー - 45%、CXOおよびディレクター - 30%、エグゼクティブ - 25
- 地域別北米：40％、欧州：25％、アジア太平洋地域：20％、中南米：10％、中東・アフリカ：5
レポート掲載企業リスト
- サーモフィッシャーサイエンティフィック社（米国）
- メルクKGaA（ドイツ）
- コーニング・インコーポレイテッド（米国）
- ロンザ（スイス）
- テカントレーディングAG（スイス）
- Avantor, Inc、
- 株式会社リプロセル（日本）
- 3D Biotek LLC.米国
- S-BIO、Vaupell Holdings Inc.
- アドバンスト・バイオマトリックス社（米国）
- UPM バイオメディカルズ（フィンランド）
- シンセコン社（米国）
- インスフェロ（スイス）
- エミュレート社（米国）
- CN Bio Innovations Ltd.英国
- シンビボ社（米国）
- カークストール社英国
- レナバイオサイエンシズ（米国）
- TissUse GmbH（ドイツ）
- Cellendes GmbH（ドイツ）
- グライナー・バイオワン・インターナショナル（ドイツ）
- AMSBIO（イギリス）
- MIMETAS B.V.（オランダ）
- プロモセル社（ドイツ）
- ナノファイバー・ソリューションズ（米国）
調査範囲
この調査レポートは、3D細胞培養市場の詳細な状況を掲載しています。製品、用途、エンドユーザー、地域など、さまざまなセグメントにわたる市場規模と今後の成長可能性を推定することを目的としています。また、主要市場プレイヤーの会社概要、最近の動向、主要市場戦略とともに、詳細な競合分析も掲載しています。

レポート購入の主なメリット
本レポートは、3D細胞培養市場全体とそのサブセグメントについて、最も近似した収益数字を提供することで、市場リーダー／新規参入者を支援します。また、利害関係者が競争状況をより良く理解し、より多くの洞察を得ることで、自社のビジネスをより良く位置づけ、適切な市場参入戦略を立てるのに役立ちます。本レポートは、関係者が市場の鼓動を理解し、主要な市場促進要因、阻害要因、機会、課題に関する情報を提供することを可能にする。
本レポートは、以下のポイントに関する洞察を提供します：
- 3D細胞培養市場の成長に影響を与える主な促進要因（動物実験の代替法開発への高い関心、個別化医療の採用拡大、政府支援と資金調達の増加、学界と研究機関の共同研究の増加）、阻害要因（3D細胞培養技術の導入にかかる高コスト、3D細胞培養における広く受け入れられた標準化または単一の標準化の欠如）、機会（マイクロ流体ベースの3D細胞培養の出現）、課題（3D細胞培養製品の一貫性の欠如、プラスチック廃棄物処理および消耗品への高い依存）の分析。
- 製品開発／イノベーション：3D細胞培養市場の新発売製品に関する詳細な洞察。
- 市場開発：有利な市場に関する包括的な情報 - さまざまな地域の3D細胞培養市場を分析している。
- 市場の多様化：3D細胞培養市場における新サービス、未開拓の地域、最近の開発、投資に関する詳細な情報。
- 競合評価：主要企業の市場シェア、成長戦略、サービス内容を詳細に評価。サーモフィッシャーサイエンティフィック社（米国）、メルクKGaA社（ドイツ）、コーニング社（米国）、ロンザ社（スイス）、アバントール社（米国）など。

ページTOPに戻る

1 INTRODUCTION 30
1.1 STUDY OBJECTIVES 30
1.2 MARKET DEFINITION 30
1.2.1 INCLUSIONS AND EXCLUSIONS 30
1.3 MARKET SCOPE 31
1.3.1 MARKETS COVERED 31
1.3.2 YEARS CONSIDERED 31
1.4 CURRENCY CONSIDERED 32
1.5 RESEARCH LIMITATIONS 32
1.6 STAKEHOLDERS 32
1.7 SUMMARY OF CHANGES 33
1.8 IMPACT OF ECONOMIC RECESSION ON 3D CELL CULTURE MARKET 33
2 RESEARCH METHODOLOGY 34
2.1 RESEARCH DATA 34
FIGURE 1 RESEARCH DESIGN 34
2.1.1 SECONDARY DATA 35
2.1.2 PRIMARY DATA 36
FIGURE 2 3D CELL CULTURE MARKET: BREAKDOWN OF PRIMARIES 36
2.2 MARKET SIZE ESTIMATION 37
FIGURE 3 3D CELL CULTURE MARKET SIZE ESTIMATION (SUPPLY SIDE ANALYSIS), 2022 37
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022 38
FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE ANALYSIS, 2022 38
2.2.1 INSIGHTS FROM PRIMARIES 40
FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS 40
2.2.2 SEGMENT ASSESSMENT (BY PRODUCT, APPLICATION, AND END USER) 40
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 40
2.3 GROWTH RATE ASSUMPTIONS 41
FIGURE 8 3D CELL CULTURE MARKET: CAGR PROJECTIONS, 2023–2028 42
FIGURE 9 3D CELL CULTURE MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES 42
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 43
FIGURE 10 DATA TRIANGULATION METHODOLOGY 43
2.5 STUDY ASSUMPTIONS 44
2.6 RISK ANALYSIS 44
2.7 IMPACT OF ECONOMIC RECESSION ON 3D CELL CULTURE MARKET 44
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2024–2028 (% GROWTH) 45
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 45
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION) 45
3 EXECUTIVE SUMMARY 46
FIGURE 11 3D CELL CULTURE MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 46
FIGURE 12 3D CELL CULTURE MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 47
FIGURE 13 3D CELL CULTURE MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 47
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF 3D CELL CULTURE MARKET 48
4 PREMIUM INSIGHTS 49
4.1 3D CELL CULTURE MARKET OVERVIEW 49
FIGURE 15 INCREASED FOCUS ON DEVELOPING ALTERNATIVES TO ANIMAL TESTING TO PROPEL MARKET 49
4.2 NORTH AMERICA: 3D CELL CULTURE MARKET, BY PRODUCT AND COUNTRY (2022) 50
FIGURE 16 SCAFFOLD-BASED 3D CELL CULTURES ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN 3D CELL CULTURE MARKET IN 2022 50
4.3 3D CELL CULTURE MARKET SHARE, BY APPLICATION, 2023 VS. 2028 51
FIGURE 17 CANCER & STEM CELL RESEARCH TO DOMINATE MARKET IN 2028 51
4.4 3D CELL CULTURE MARKET SHARE, BY END USER, 2022 (USD MILLION) 51
FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES DOMINATED 3D CELL CULTURE MARKET IN 2022 51
4.5 3D CELL CULTURE MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 52
FIGURE 19 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE FROM 2023 TO 2028 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
FIGURE 20 3D CELL CULTURE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53
TABLE 4 3D CELL CULTURE MARKET: IMPACT ANALYSIS 54
5.2.1 DRIVERS 54
5.2.1.1 High focus on developing alternatives to animal testing 54
5.2.1.2 Greater adoption of personalized medicine globally for multiple diseases 55
5.2.1.3 Increased government support and funding for 3D cell culture 56
5.2.1.4 Increased industry-academia collaboration on 3D cell culture and research 57
5.2.2 RESTRAINTS 57
5.2.2.1 High costs of implementing 3D cell culture technologies 57
5.2.2.2 Lack of widely accepted or single standardization in 3D cell culture 58
5.2.3 OPPORTUNITIES 58
5.2.3.1 Emergence of microfluidics-based 3D cell culture 58
5.2.3.2 High growth opportunities and booming biopharmaceutical sector in emerging economies 59
5.2.4 CHALLENGES 59
5.2.4.1 Lack of consistency in 3D cell culture products 59
5.2.4.2 High dependence on plastic waste disposals and consumables 60
TABLE 5 COMPARISON OF SINGLE-USE BIOPROCESSING SYSTEM DISPOSAL OPTIONS 60
5.3 RANGES/SCENARIOS 61
FIGURE 21 SCENARIOS BASED ON IMPACT OF UNCERTAINTIES ON GROWTH OF 3D CELL CULTURE MARKET 61
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 61
5.5 VALUE CHAIN ANALYSIS 62
FIGURE 22 VALUE CHAIN ANALYSIS OF 3D CELL CULTURE MARKET: RAW MATERIAL AND MANUFACTURING PHASE ADD MAXIMUM VALUE 62
5.6 SUPPLY CHAIN ANALYSIS 63
FIGURE 23 3D CELL CULTURE MARKET: SUPPLY CHAIN ANALYSIS 64
5.7 ECOSYSTEM ANALYSIS 64
FIGURE 24 ECOSYSTEM ANALYSIS: 3D CELL CULTURE MARKET 64
TABLE 6 3D CELL CULTURE MARKET: ROLE IN ECOSYSTEM 65
5.8 PORTER’S FIVE FORCES ANALYSIS 66
TABLE 7 3D CELL CULTURE MARKET: PORTER’S FIVE FORCES ANALYSIS 66
5.8.1 THREAT OF NEW ENTRANTS 66
5.8.2 THREAT OF SUBSTITUTES 66
5.8.3 BARGAINING POWER OF SUPPLIERS 66
5.8.4 BARGAINING POWER OF BUYERS 67
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 67
5.9 PATENT ANALYSIS 67
5.9.1 LIST OF MAJOR PATENTS 68
5.10 PRICING ANALYSIS 69
TABLE 8 SELLING PRICE OF 3D CELL CULTURE PRODUCTS BY TOP PLAYERS (2022) 69
TABLE 9 AVERAGE SELLING PRICE, BY APPLICATION (2022) 70
5.11 TECHNOLOGY ANALYSIS 70
TABLE 10 ADVANTAGES AND DISADVANTAGES OF 3D CELL CULTURE TECHNIQUES 70
5.12 REGULATORY ANALYSIS 71
5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71
TABLE 11 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71
TABLE 12 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
TABLE 13 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
TABLE 14 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
5.13 KEY CONFERENCES AND EVENTS IN 2023 74
TABLE 15 3D CELL CULTURE MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023 74
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 75
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 75
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF 3D CELL CULTURE PRODUCTS 75
5.14.2 BUYING CRITERIA 76
FIGURE 26 KEY BUYING CRITERIA FOR END USERS 76
6 3D CELL CULTURE MARKET, BY PRODUCT 77
6.1 INTRODUCTION 78
TABLE 16 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 78
6.2 SCAFFOLD-BASED 3D CELL CULTURES 78
TABLE 17 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 79
TABLE 18 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY REGION, 2021–2028 (USD MILLION) 79
TABLE 19 NORTH AMERICA: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION) 79
TABLE 20 EUROPE: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION) 80
TABLE 21 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION) 80
6.2.1 HYDROGELS/ECM ANALOGS 80
6.2.1.1 Hydrogels/ECM analogs to dominate scaffold-based 3D cell cultures market during forecast period 80
TABLE 22 HYDROGELS/ECM ANALOGS MARKET, BY REGION, 2021–2028 (USD MILLION) 81
TABLE 23 NORTH AMERICA: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 81
TABLE 24 EUROPE: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 25 ASIA PACIFIC: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82
6.2.2 NATURAL & SYNTHETIC HYDROGELS 82
6.2.2.1 Easy synthetization on large scale and improved control of matrix architecture to propel segment 82
TABLE 26 HYDROGELS/ECM ANALOGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 83
6.2.3 SOLID SCAFFOLDS 83
6.2.3.1 Solid scaffolds to be widely adopted in regenerative medicine and preclinical in-vitro testing 83
TABLE 27 SOLID SCAFFOLDS MARKET, BY REGION, 2021–2028 (USD MILLION) 84
TABLE 28 NORTH AMERICA: SOLID SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 29 EUROPE: SOLID SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 85
TABLE 30 ASIA PACIFIC: SOLID SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 85

6.2.4 MICROPATTERNED SURFACES 85
6.2.4.1 Micropatterned surfaces to enhance expression of enzyme levels and drug reactivity 85
TABLE 31 MICROPATTERNED SURFACES MARKET, BY REGION, 2021–2028 (USD MILLION) 86
TABLE 32 NORTH AMERICA: MICROPATTERNED SURFACES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 33 EUROPE: MICROPATTERNED SURFACES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 34 ASIA PACIFIC: MICROPATTERNED SURFACES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 87
6.3 SCAFFOLD-FREE 3D CELL CULTURES 88
TABLE 35 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 88
TABLE 36 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY REGION, 2021–2028 (USD MILLION) 88
TABLE 37 NORTH AMERICA: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 38 EUROPE: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 39 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION) 90
6.3.1 LOW ATTACHMENT PLATES 90
6.3.1.1 Low attachment plates to grow at highest rate in scaffold-free 3D cell cultures market 90
TABLE 40 LOW ATTACHMENT PLATES MARKET, BY REGION, 2021–2028 (USD MILLION) 91
TABLE 41 NORTH AMERICA: LOW ATTACHMENT PLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 42 EUROPE: LOW ATTACHMENT PLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 43 ASIA PACIFIC: LOW ATTACHMENT PLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
6.3.2 HANGING DROP PLATES 93
6.3.2.1 Hanging drop plates to be mostly used in stem cell differentiation and cytotoxicity research 93
TABLE 44 HANGING DROP PLATES MARKET, BY REGION, 2021–2028 (USD MILLION) 93
TABLE 45 NORTH AMERICA: HANGING DROP PLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 46 EUROPE: HANGING DROP PLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 47 ASIA PACIFIC: HANGING DROP PLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
6.3.3 3D BIOREACTORS 95
6.3.3.1 3D bioreactors to be commonly used in mass production of cells 95
TABLE 48 3D BIOREACTORS MARKET, BY REGION, 2021–2028 (USD MILLION) 96
TABLE 49 NORTH AMERICA: 3D BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 96
TABLE 50 EUROPE: 3D BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 97
TABLE 51 ASIA PACIFIC: 3D BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 97
6.3.4 3D PETRI DISHES 98
6.3.4.1 Europe to witness highest growth in 3D Petri dishes during study period 98
TABLE 52 3D PETRI DISHES MARKET, BY REGION, 2021–2028 (USD MILLION) 98
TABLE 53 NORTH AMERICA: 3D PETRI DISHES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 98
TABLE 54 EUROPE: 3D PETRI DISHES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 55 ASIA PACIFIC: 3D PETRI DISHES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 99
6.4 MICROFLUIDICS-BASED 3D CELL CULTURES 100
6.4.1 MICROFLUIDICS-BASED 3D CELL CULTURES TO GROW AT HIGHEST RATE DURING FORECAST PERIOD 100
TABLE 56 3D CELL CULTURE MARKET FOR MICROFLUIDICS-BASED 3D CELL CULTURES, BY REGION, 2021–2028 (USD MILLION) 100
TABLE 57 NORTH AMERICA: 3D CELL CULTURE MARKET FOR MICROFLUIDICS-BASED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 58 EUROPE: 3D CELL CULTURE MARKET FOR MICROFLUIDICS-BASED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 59 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR 3D MICROFLUIDICS-BASED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION) 101
6.5 MAGNETIC & BIOPRINTED 3D CELL CULTURES 102
6.5.1 3D CELL CULTURE TO BE FORMED WITHOUT MEDIA IN MAGNETIC LEVITATION 102
TABLE 60 3D CELL CULTURE MARKET FOR MAGNETIC & BIOPRINTED 3D CELL CULTURES, BY REGION, 2021–2028 (USD MILLION) 102
TABLE 61 NORTH AMERICA: 3D CELL CULTURE MARKET FOR MAGNETIC & BIOPRINTED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 62 EUROPE: 3D CELL CULTURE MARKET FOR MAGNETIC & BIOPRINTED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 63 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR MAGNETIC & BIOPRINTED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION) 103
7 3D CELL CULTURE MARKET, BY END USER 104
7.1 INTRODUCTION 105
TABLE 64 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION) 105
7.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 105
7.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO BE LARGEST END USERS OF 3D CELL CULTURE PRODUCTS 105
TABLE 65 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 106
TABLE 66 NORTH AMERICA: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 67 EUROPE: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 68 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 107
7.3 RESEARCH INSTITUTES 108
7.3.1 INCREASED GOVERNMENT FUNDING FOR RESEARCH AND HIGH PREVALENCE OF CANCER TO AUGMENT MARKET 108
TABLE 69 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 109
TABLE 70 NORTH AMERICA: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 71 EUROPE: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 110
TABLE 72 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 110
7.4 COSMETICS INDUSTRY 111
7.4.1 FOCUS ON DEVELOPING ALTERNATIVES FOR ANIMAL TESTING TO FUEL MARKET 111
TABLE 73 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY REGION, 2021–2028 (USD MILLION) 111
TABLE 74 NORTH AMERICA: 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 75 EUROPE: 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 76 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION) 112
7.5 OTHER END USERS 113
TABLE 77 3D CELL CULTURE MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 113
TABLE 78 NORTH AMERICA: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 79 EUROPE: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 80 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 114
8 3D CELL CULTURE MARKET, BY APPLICATION 115
8.1 INTRODUCTION 116
TABLE 81 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 116
8.2 CANCER & STEM CELL RESEARCH 116
8.2.1 RISING PREVALENCE OF CANCER AND OTHER COMPLEX DISEASES GLOBALLY TO PROPEL MARKET 116
TABLE 82 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY REGION, 2021–2028 (USD MILLION) 117
TABLE 83 NORTH AMERICA: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 84 EUROPE: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 85 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 118
8.3 DRUG DISCOVERY & TOXICOLOGY TESTING 119
8.3.1 INCREASED ADOPTION OF PERSONALIZED MEDICINES AND EXPANSION OF PHARMACEUTICAL COMPANIES TO SUPPORT MARKET 119
TABLE 86 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY REGION, 2021–2028 (USD MILLION) 119
TABLE 87 NORTH AMERICA: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 88 EUROPE: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 89 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 121
8.4 TISSUE ENGINEERING & REGENERATIVE MEDICINE 121
8.4.1 INCREASING RESEARCH ON 3D CULTURE TECHNIQUES TO AID MARKET 121
TABLE 90 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2021–2028 (USD MILLION) 122
TABLE 91 NORTH AMERICA: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 92 EUROPE: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 93 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION) 123
9 3D CELL CULTURE MARKET, BY REGION 124
9.1 INTRODUCTION 125
TABLE 94 3D CELL CULTURE MARKET, BY REGION, 2021–2028 (USD MILLION) 125
9.2 NORTH AMERICA 126
FIGURE 27 NORTH AMERICA: 3D CELL CULTURE MARKET SNAPSHOT 126
TABLE 95 NORTH AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 96 NORTH AMERICA: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 127
TABLE 97 NORTH AMERICA: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 127
TABLE 98 NORTH AMERICA: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 128
TABLE 99 NORTH AMERICA: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 128
TABLE 100 NORTH AMERICA: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION) 129
9.2.1 US 129
9.2.1.1 Adoption of innovative techniques and government-funded initiatives to drive market 129
TABLE 101 US: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 130
TABLE 102 US: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 130
TABLE 103 US: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 131
TABLE 104 US: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 131
TABLE 105 US: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION) 132
9.2.2 CANADA 132
9.2.2.1 Advancements in regenerative medicine to boost market 132
TABLE 106 CANADA: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 133
TABLE 107 CANADA: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 133
TABLE 108 CANADA: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 134
TABLE 109 CANADA: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 134
TABLE 110 CANADA: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION) 135
9.2.3 NORTH AMERICA: RECESSION IMPACT 135
9.3 EUROPE 136
TABLE 111 EUROPE: 3D CELL CULTURE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 112 EUROPE: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 137
TABLE 113 EUROPE: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 137
TABLE 114 EUROPE: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 138
TABLE 115 EUROPE: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 138
TABLE 116 EUROPE: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION) 139
9.3.1 GERMANY 139
9.3.1.1 Spike in investments by key players and growing funding from government organizations to fuel market 139
TABLE 117 GERMANY: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 140
TABLE 118 GERMANY: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 140
TABLE 119 GERMANY: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 141
TABLE 120 GERMANY: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 141
TABLE 121 GERMANY: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION) 142
9.3.2 UK 142
9.3.2.1 Growth in life sciences industry to drive market 142
TABLE 122 UK: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 143
TABLE 123 UK: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 143
TABLE 124 UK: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 144
TABLE 125 UK: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 144
TABLE 126 UK: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION) 145
9.3.3 FRANCE 145
9.3.3.1 Growth in biotechnology industry to propel market 145
TABLE 127 FRANCE: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 146
TABLE 128 FRANCE: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 146
TABLE 129 FRANCE: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 130 FRANCE: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 147
TABLE 131 FRANCE: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION) 148
9.3.4 ITALY 148
9.3.4.1 Increase in research activities and funds to boost market 148
TABLE 132 ITALY: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 149
TABLE 133 ITALY: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 134 ITALY: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 150
TABLE 135 ITALY: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 150
TABLE 136 ITALY: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION) 151
9.3.5 SPAIN 151
9.3.5.1 Increased collaborations in research and focus on personalized medicine to drive market 151
TABLE 137 SPAIN: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 152
TABLE 138 SPAIN: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 139 SPAIN: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 140 SPAIN: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 153
TABLE 141 SPAIN: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION) 154
9.3.6 REST OF EUROPE 154
TABLE 142 REST OF EUROPE: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 155
TABLE 143 REST OF EUROPE: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 144 REST OF EUROPE: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 145 REST OF EUROPE: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 156
TABLE 146 REST OF EUROPE: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION) 157
9.3.7 EUROPE: RECESSION IMPACT 157
9.4 ASIA PACIFIC 158
FIGURE 28 ASIA PACIFIC: 3D CELL CULTURE MARKET SNAPSHOT 158
TABLE 147 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 159
TABLE 148 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 159
TABLE 149 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 160
TABLE 150 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 160
TABLE 151 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 160
TABLE 152 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION) 161
9.4.1 CHINA 161
9.4.1.1 Government support and strategic initiatives by key players to strengthen use of biotechnology 161
TABLE 153 CHINA: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 162
TABLE 154 CHINA: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 162
TABLE 155 CHINA: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 156 CHINA: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 163
TABLE 157 CHINA: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION) 164
9.4.2 JAPAN 164
9.4.2.1 Rising prevalence of cancer and increased adoption of 3D cell culture to augment market growth 164
TABLE 158 JAPAN: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 165
TABLE 159 JAPAN: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 165
TABLE 160 JAPAN: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 166
TABLE 161 JAPAN: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 166
TABLE 162 JAPAN: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION) 167

9.4.3 INDIA 167
9.4.3.1 Growth in life sciences industry to support market 167
TABLE 163 INDIA: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 168
TABLE 164 INDIA: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 165 INDIA: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 169
TABLE 166 INDIA: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 169
TABLE 167 INDIA: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION) 170
9.4.4 REST OF ASIA PACIFIC 170
TABLE 168 REST OF ASIA PACIFIC: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 171
9.4.5 ASIA PACIFIC: RECESSION IMPACT 171
TABLE 169 REST OF ASIA PACIFIC: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 170 REST OF ASIA PACIFIC: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 171 REST OF ASIA PACIFIC: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 173
TABLE 172 REST OF ASIA PACIFIC: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION) 173
9.5 LATIN AMERICA 174
9.5.1 GROWING GOVERNMENT INVESTMENTS AND AVAILABILITY OF GRANTS FOR CELL-BASED RESEARCH TO DRIVE MARKET 174
TABLE 173 LATIN AMERICA: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 174
TABLE 174 LATIN AMERICA: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 175 LATIN AMERICA: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 176 LATIN AMERICA: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 176
TABLE 177 LATIN AMERICA: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION) 176
9.5.2 LATIN AMERICA: RECESSION IMPACT 176
9.6 MIDDLE EAST & AFRICA 177
9.6.1 INCREASED FUNDING INITIATIVES AND STRATEGIC PARTNERSHIPS IN RESEARCH TO AID MARKET 177
TABLE 178 MIDDLE EAST & AFRICA: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 177
TABLE 179 MIDDLE EAST & AFRICA: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 180 MIDDLE EAST & AFRICA: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 181 MIDDLE EAST & AFRICA: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 179
TABLE 182 MIDDLE EAST & AFRICA: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION) 179
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 179
10 COMPETITIVE LANDSCAPE 180
10.1 INTRODUCTION 180
10.2 STRATEGIES ADOPTED BY KEY PLAYERS 181
FIGURE 29 3D CELL CULTURE MARKET: STRATEGIES ADOPTED BY KEY PLAYERS 181
10.3 REVENUE SHARE ANALYSIS 182
FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022 182
10.4 MARKET SHARE ANALYSIS 182
FIGURE 31 3D CELL CULTURE MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022 183
TABLE 183 3D CELL CULTURE MARKET: DEGREE OF COMPETITION 183
10.5 COMPANY EVALUATION QUADRANT 184
10.5.1 STARS 184
10.5.2 EMERGING LEADERS 185
10.5.3 PERVASIVE PLAYERS 185
10.5.4 PARTICIPANTS 185
FIGURE 32 3D CELL CULTURE MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 186
10.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 187
10.6.1 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES) 187
TABLE 184 3D CELL CULTURE MARKET: COMPANY PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS 187
10.6.2 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES) 188
TABLE 185 3D CELL CULTURE MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS 188
10.7 COMPANY EVALUATION QUADRANT: START-UPS/SMES 189
10.7.1 PROGRESSIVE COMPANIES 189
10.7.2 STARTING BLOCKS 189
10.7.3 RESPONSIVE COMPANIES 189
10.7.4 DYNAMIC COMPANIES 189
FIGURE 33 3D CELL CULTURE MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 190
10.8 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS 191
TABLE 186 3D CELL CULTURE MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS 191
TABLE 187 3D CELL CULTURE MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SME PLAYERS 192
10.9 COMPETITIVE SCENARIOS AND TRENDS 193
10.9.1 PRODUCT LAUNCHES 193
TABLE 188 3D CELL CULTURE MARKET: PRODUCT LAUNCHES, JANUARY 2020–APRIL 2023 193
10.9.2 DEALS 193
TABLE 189 3D CELL CULTURE MARKET: DEALS, JANUARY 2020–APRIL 2023 193
10.9.3 OTHER DEVELOPMENTS 194
TABLE 190 3D CELL CULTURE MARKET: OTHER DEVELOPMENTS, JANUARY 2020–APRIL 2023 194
11 COMPANY PROFILES 195
11.1 KEY PLAYERS 195
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1 THERMO FISHER SCIENTIFIC, INC. 195
TABLE 191 THERMO FISHER SCIENTIFIC, INC.: COMPANY OVERVIEW 195
FIGURE 34 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022) 196
11.1.2 MERCK KGAA 199
TABLE 192 MERCK KGAA: COMPANY OVERVIEW 199
FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2022) 200
11.1.3 CORNING INCORPORATED 203
TABLE 193 CORNING INCORPORATED: COMPANY OVERVIEW 203
FIGURE 36 CORNING INCORPORATED: COMPANY SNAPSHOT (2022) 204
11.1.4 LONZA 207
TABLE 194 LONZA: COMPANY OVERVIEW 207
FIGURE 37 LONZA: COMPANY SNAPSHOT (2022) 208
11.1.5 TECAN TRADING AG 210
TABLE 195 TECAN TRADING AG: COMPANY OVERVIEW 210
FIGURE 38 TECAN TRADING AG: COMPANY SNAPSHOT (2022) 211
11.1.6 AVANTOR, INC. 212
TABLE 196 AVANTOR, INC.: COMPANY OVERVIEW 212
FIGURE 39 AVANTOR, INC: COMPANY SNAPSHOT (2022) 212
11.1.7 REPROCELL INC. 214
TABLE 197 REPROCELL: COMPANY OVERVIEW 214
11.1.8 3D BIOTEK LLC 218
TABLE 198 3D BIOTEK LLC: COMPANY OVERVIEW 218
11.1.9 EMULATE, INC. 219
TABLE 199 EMULATE, INC.: COMPANY OVERVIEW 219
11.1.10 SYNTHECON, INCORPORATED 221
TABLE 200 SYNTHECON, INCORPORATED: COMPANY OVERVIEW 221
11.1.11 INSPHERO AG 223
TABLE 201 INSPHERO AG: COMPANY OVERVIEW 223
11.1.12 KIRKSTALL LTD. 225
TABLE 202 KIRKSTALL LTD.: COMPANY OVERVIEW 225
11.1.13 GREINER BIO-ONE INTERNATIONAL GMBH 226
TABLE 203 GREINER BIO-ONE INTERNATIONAL GMBH: COMPANY OVERVIEW 226
11.1.14 PROMOCELL GMBH 227
TABLE 204 PROMOCELL GMBH: COMPANY OVERVIEW 227
11.1.15 UPM BIOMEDICALS 228
TABLE 205 UPM: COMPANY OVERVIEW 228
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS 229
11.2.1 CN BIO INNOVATIONS LTD. 229
11.2.2 TISSUSE GMBH 230
11.2.3 LENA BIOSCIENCES INC. 231
11.2.4 CELLENDES GMBH 232
11.2.5 ADVANCED BIOMATRIX, INC. (PART OF BICO) 233
11.2.6 SYNVIVO INC. 234
11.2.7 AMSBIO 235
11.2.8 MIMETAS BV 236
11.2.9 S-BIO, VAUPELL HOLDINGS INC. (A GROUP COMPANY OF SUMITOMO BAKELITE CO., LTD.) 237
11.2.10 NANOFIBER SOLUTIONS 237
12 APPENDIX 238
12.1 DISCUSSION GUIDE 238
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 241
12.3 CUSTOMIZATION OPTIONS 243
12.4 RELATED REPORTS 243
12.5 AUTHOR DETAILS 244

ページTOPに戻る

Table of Contents

Summary

The global 3D cell culture market size is projected to reach USD 2.5 billion by 2028 from USD 1.3 billion in 2023, at a CAGR of 14.6% during the forecast period. Factors such as increased adoption of 3D cell culture coupled with increased funding for 3D cell culture research is driving the market growth.
“The scaffold-based 3D cell culture product segment accounted for the highest growth rate in the 3D cell culture market, by drug class, during the forecast period”
Based on product, the 3D cell culture market is segmented into scaffold-based 3D cell cultures, scaffold-free 3D cell cultures, microfluidics-based 3D cell cultures, and magnetic & bioprinted 3D cell cultures. The scaffold-based 3D cell cultures segment accounted for the largest share in 2022. Rising demand for hydrogels across various pharmaceutical industries is likely to have positive impact on the growth of scaffold-based 3D cell culture market.
“Cancer and Stem cell research segment accounted for the largest share of the application segment in 2022.”
Based on application, the market is segmented into cancer & stem cell research, drug discovery & toxicology testing, and tissue engineering & regenerative medicine. Cancer & stem cell segment research accounted for the largest market share in the market in 2022. The increasing prevalence of cancer and significant funding initiatives for cancer research from the government and the private sector are major factors driving the growth of this application segment.
“Asia Pacific region is likely to grow at a faster pace.”
The 3D cell culture market is segmented into Europe, Asia Pacific, North America, latin America and Middle East and Africa. The APAC market is expected to be the fastest-growing regional segment during the forecast period due the presence of favorable regulatory guidelines, government support for cell culture-based vaccine production, low manufacturing costs, and the growing focus of global market players on emerging Asian countries.
The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 70%, and Demand Side - 30%
• By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%
• By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, and Middle East and Africa -5%
Lists of Companies Profiled in the Report:
• Thermo Fisher Scientific, Inc. (US)
• Merck KGaA (Germany)
• Corning Incorporated (US)
• Lonza (Switzerland)
• Tecan Trading AG (Switzerland)
• Avantor, Inc.(US),
• REPROCELL Inc. (Japan)
• 3D Biotek LLC. (US)
• S-BIO, Vaupell Holdings Inc. (US)
• Advanced BioMatrix, Inc. (US)
• UPM Biomedicals (Finland)
• SYNTHECON, INCORPORATED (US)
• InSphero (Switzerland)
• Emulate, Inc. (US)
• CN Bio Innovations Ltd. (UK)
• SynVivo, Inc.(US)
• Kirkstall Ltd. (UK)
• Lena Biosciences (US)
• TissUse GmbH (Germany)
• Cellendes GmbH (Germany)
• Greiner Bio-one International GmbH (Germany)
• AMSBIO (UK)
• MIMETAS B.V.(Netherlands)
• Promocell GmbH (Germany)
• Nanofiber Solutions (US)
Research Coverage:
This report provides a detailed picture of the 3D cell culture market. It aims at estimating the size and future growth potential of the market across different segments, such as product, application, end user and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall 3D cell culture market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
• Analysis of key drivers (high focus on developing alterantives to animal testing, greater adoption of personalized medicine, increased government support and funding, increased academia-research collabrations), restraints (high cost of implementing 3D cell culture technologies, lack of widely accepted or single standardization in 3D cell culture), opportunities (emergence of microfluidic based 3D cell culture), and challenges (lack of consistency in 3D cell culture products, high dependency on plastic waste disposals and consumables) influencing the growth of 3D cell culture market.
• Product Development/Innovation: Detailed insights on newly launched products of the 3D cell culture market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the 3D cell culture market across varied regions.
• Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the 3D cell culture market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players . Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Corning Incorporated (US), Lonza (Switzerland), and Avantor Inc. (US) and among others in the 3D cell culture market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（バイオ薬物）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（stem cell）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（バイオ薬物）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（stem cell）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?